Xenon
Xenon is a colourless, odourless, inert noble gas that has medical applications, particularly in anaesthesia and diagnostic imaging. It is primarily used as an inhalational general anaesthetic and has also been investigated for its neuroprotective properties. It works by modulating neuronal ion channels and neurotransmitter receptors, including NMDA receptors, thereby reducing nerve cell activity and producing anaesthesia. Xenon helps induce and maintain unconsciousness and provides analgesic effects during surgical procedures. It is administered through inhalation using specialised anaesthesia equipment. It has a relatively rapid onset and recovery because it is eliminated mainly through the lungs without significant metabolism. Possible adverse effects include nausea, vomiting, dizziness, and cardiovascular changes. Its use is limited by high cost, specialised equipment requirements, and limited availability. Administration requires trained anaesthesia professionals and continuous monitoring of vital signs.
Xenon was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Xenon, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Xenon from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Xenon, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
